Evidence map›Paper›PMID 34485225›Full record

ArticleFrontiers in public health2021

A Modern Genotoxicity Testing Paradigm: Integration of the High-Throughput CometChip® and the TGx-DDI Transcriptomic Biomarker in Human HepaRG™ Cell Cultures.

Julie K Buick, Andrew Williams, Matthew J Meier, Carol D Swartz, Leslie Recio, Rémi Gagné, Stephen S Ferguson, Bevin P Engelward, Carole L Yauk

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Advancing genotoxicity assessment with transcriptomic biomarkers: from 2D to 3D HepaRG spheroid models.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. TGx-DDI (toxicogenomic DNA damage-inducing) biomarker validation: multi-site ring trial supporting regulatory use.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  9. Transferability and Reproducibility of the HepaRG CometChip Assay.Environmental and molecular mutagenesis · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. HepaRGNAM journal · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Application of HepaRG cells for genotoxicity assessment: a review.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Julie K BuickEnvironmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
Andrew WilliamsEnvironmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
Matthew J MeierEnvironmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
Carol D SwartzIntegrated Laboratory Systems Inc. (ILS), Research Triangle Park, Durham, NC, United States.
Leslie RecioIntegrated Laboratory Systems Inc. (ILS), Research Triangle Park, Durham, NC, United States.
Rémi GagnéEnvironmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
Stephen S FergusonNational Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, United States.
Bevin P EngelwardDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.
Carole L YaukEnvironmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
Health Canada · CAIntegrated Laboratory Systems, Inc. · USMassachusetts Institute of Technology · USNational Institute of Environmental Health Sciences · US

Funding

The MIT Superfund Research Program: A Systems Approach for the Protection of Human Health from Hazardous ChemicalsP42ES027707 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Desiree Plata · 2017 to 2026
$22.2M
NIEHS NIH HHS P42 ES027707
6 · The paper itself

Abstract

Higher-throughput, mode-of-action-based assays provide a valuable approach to expedite chemical evaluation for human health risk assessment. In this study, we combined the high-throughput alkaline DNA damage-sensing CometChip

Indexed as

Gene Expression ProfilingTranscriptomeCell Culture TechniquesCell LineGenetic MarkersHumansMutagensGenetic MarkersMutagensgenetic toxicologyhuman health risk assessmentmetabolic activationTGx-28.65 genomic biomarkerTGx-DDI genomic biomarkertoxicogenomics

Identifiers

PMID34485225
PMCPMC8416458
OpenAlexW3193856759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.